4.6 Article

Molnupiravir Inhibits Porcine Epidemic Diarrhea Virus Infection In Vitro

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection

Gregory R. Bluemling et al.

Summary: The 2013-2016 Ebola virus epidemic in West Africa was unprecedented in magnitude, resulting in over 11,000 deaths and causing a global public health emergency. A second outbreak in 2018-2020 in DRC resulted in additional cases and deaths. The development of effective oral therapeutic agents for self-administration is crucial in combating future outbreaks. This study demonstrates the effectiveness of N4-hydroxycytidine (EIDD-1931) in treating lethal EBOV infection in murine models, with promising results for further investigation of molnupiravir as a potential treatment for Ebola virus disease.

ANTIVIRAL RESEARCH (2023)

Article Immunology

Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords

Adarsh Bhimraj et al.

Summary: Emergency use authorizations (EUAs) provide much-needed therapies during pandemics, but when issued before sufficient evidence is available, may have unintended consequences. They can potentially promote ineffective therapies and hinder evidence generation. We need a transparent evidence-based process for EUA.

CLINICAL INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial

I'ah Donovan-Banfield et al.

Summary: This study investigates the impact of molnupiravir treatment on the genomic changes in SARS-CoV-2 and finds that it significantly increases the transition:transversion mutation ratio without causing specific resistance mutations.

NATURE COMMUNICATIONS (2022)

Review Veterinary Sciences

Research Progress on the NSP9 Protein of Porcine Reproductive and Respiratory Syndrome Virus

Huiyang Sha et al.

Summary: This article comprehensively reviews the application of NSP9, a non-structural protein of PRRSV, in genetic evolution analysis, interaction with host proteins, interaction with other viral proteins, pathogenicity, regulation of cellular immune response, antiviral drugs, vaccines, and detection methods. The review provides innovative ideas and strategies for PRRSV prevention and control.

FRONTIERS IN VETERINARY SCIENCE (2022)

Review Virology

Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus-Host Interactions

Yuanzhu Zhang et al.

Summary: This article reviews the latest progress in the biology of PEDV, including its transmission and origin, structure and function, evolution, and virus-host interaction, in an attempt to find potential virulence factors influencing PEDV pathogenesis. The findings serve as a valuable reference for the development of vaccines and control of infection.

VIRUSES-BASEL (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

Angela Wahl et al.

Summary: The study suggests that bats may be the source of coronaviruses that can be directly transmitted to humans. Using the LoM model, efficient replication of SARS-CoV, MERS-CoV, SARS-CoV-2, and two SARS-like bat coronaviruses in human lung tissue was demonstrated. Infection with SARS-CoV-2 predominantly targets human lung epithelial cells and induces a sustained inflammatory response. The broad-spectrum antiviral agent EIDD-2801 significantly inhibits SARS-CoV-2 replication in vivo, showing potential for prevention and treatment of COVID-19.

NATURE (2021)

Article Biochemistry & Molecular Biology

Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template

Calvin J. Gordon et al.

Summary: The study found that Molnupiravir or NHC can increase the mutation frequencies in replicating coronaviruses, leading to enhanced antiviral effects; NHC-TP primarily competes with CTP for incorporation, resulting in RNA mutations; Biochemical data support a mechanism of action of Molnupiravir that is primarily based on RNA mutagenesis mediated via the template strand.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Pharmacology & Pharmacy

A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase

Jianyuan Zhao et al.

Summary: Antiviral therapeutics are crucial in combating the COVID-19 pandemic, and a cell-based assay for SARS-CoV-2 RdRp has been developed to evaluate the efficacy of nucleotide analog inhibitors and their resistance to viral exoribonuclease-mediated proofreading. Molnupiravir and Remdesivir showed strong inhibition of SARS-CoV-2 RdRp, with Molnupiravir demonstrating the lowest EC50 value and Remdesivir having the highest resistance to exoribonuclease activity.

ANTIVIRAL RESEARCH (2021)

Article Biochemistry & Molecular Biology

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis

Florian Kabinger et al.

Summary: Molnupiravir is an oral antiviral drug candidate that increases viral RNA mutations frequency and inhibits replication of SARS-CoV-2 by altering the substrate preference of RdRp. This two-step mutagenesis mechanism can explain the broad-spectrum antiviral activity of molnupiravir, making it a promising COVID-19 treatment option.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

Article Biochemistry & Molecular Biology

β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway

Sourish Ghosh et al.

Article Microbiology

Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses

Jeong-Joong Yoon et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Agriculture, Dairy & Animal Science

Antiviral Compounds Against Nucleocapsid Protein of Porcine Epidemic Diarrhea Virus

Nipaporn Deejai et al.

ANIMAL BIOTECHNOLOGY (2017)